购物车
- 全部删除
- 您的购物车当前为空
Protease-Activated Receptor-1, PAR-1 Agonist acetate 是一种选择性蛋白酶激活受体 1 (PAR-1) 激动剂肽。 它对应于 PAR1 栓系配体,可以选择性地模拟凝血酶通过该受体的作用。
Protease-Activated Receptor-1, PAR-1 Agonist acetate 是一种选择性蛋白酶激活受体 1 (PAR-1) 激动剂肽。 它对应于 PAR1 栓系配体,可以选择性地模拟凝血酶通过该受体的作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 773 | 现货 | |
2 mg | ¥ 1,050 | 现货 | |
5 mg | ¥ 1,590 | 现货 | |
10 mg | ¥ 2,270 | 现货 | |
25 mg | ¥ 3,580 | 现货 | |
50 mg | ¥ 4,920 | 现货 | |
100 mg | ¥ 6,780 | 现货 | |
200 mg | ¥ 9,130 | 现货 |
产品描述 | Protease-Activated Receptor-1, PAR-1 Agonist acetate is a selective proteinase-activated receptor1 (PAR-1) agonist peptide. Protease-Activated Receptor-1, PAR-1 Agonist acetate corresponds to PAR1 tethered ligand and which can selectively mimic theactions of thrombin via this receptor[1][2]. |
体外活性 | Protease-Activated Receptor-1, PAR-1 Agonist acetat 在表达PAR1内源基因的人类HT-29结肠癌细胞中诱导蛋白激酶C(protein kinase C, PKC)同工酶α和ε的激活。在细胞水平上,Protease-Activated Receptor-1, PAR-1 Agonist acetat和凝血酶通过PKCε依赖机制促进了HT-29细胞的迁移和基质附着,这一结论是因为PAR1介导的效应被PKC抑制剂bisindolylmaleimide I 和PKCε转位抑制肽EAVSLKPT的抑制所证实,而不是由PKC抑制剂G 6976[2]的抑制所证实。 |
分子量 | 822.95 |
分子式 | C37H62N10O11 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | H2O: 20 mg/mL (24.3 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.